742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Gastroenterology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(18)30932-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Recent Advances in Gut Microbiota in Psoriatic Arthritis

  2025cites this paper
• Human gut microbial ecology and association with postbiotics; prophylactic and diagnostic application

  2024cites this paper
• Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome Patients

  2022cites this paper
• Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection

  2020cites this paper
• Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice

  2020cites this paper
• Delivery routes for faecal microbiota transplants: Available, anticipated and aspired.

  2020cites this paper
• Letter: faecal microbiota transplantation for irritable bowel syndrome—room for improvement

  2020cites this paper
• Human gut microbiota/microbiome in health and diseases: a review

  2020cites this paper
• A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

  2020cites this paper
• ACG Clinical Guideline: Management of Irritable Bowel Syndrome.

  2020cites this paper
• This is a repository copy of Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

  2020cites this paper
• Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome

  2019cites this paper
• The Super-Donor Phenomenon in Fecal Microbiota Transplantation

  2019cites this paper
• The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.

  2019cites this paper
• Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation

  2019cites this paper
• The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications.

  2019cites this paper
• Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

  2019cites this paper
• Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

  2019influential citation
• Factors affecting the composition of the gut microbiota, and its modulation

  2019cites this paper
• Fecal microbiota transfer for bowel disorders: efficacy or hype?

  2018cites this paper
• The gut microbiome and irritable bowel syndrome

  2018cites this paper